Borderline Resectable Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Borderline Resectable Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study [Phase 2]
A Phase 2 clinical trial update for the PIONEER-Panc study evaluating new and emerging therapies for pancreatic cancer at various stages (re…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1]
A Phase 1 clinical trial of PTM-101 for pancreatic ductal adenocarcinoma and related locally advanced or borderline resectable disease is cu…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial from Wake Forest University Health Sciences is evaluating neoadjuvant chemotherapy for borderline resectable and lo…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer
A cohort study evaluating circulating tumor DNA minimal residual disease (ctDNA MRD) in neoadjuvant therapy for pancreatic cancer, including…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)
NORPACT-2 is a neoadjuvant chemotherapy trial for locally advanced and borderline resectable pancreatic adenocarcinoma, sponsored by Oslo Un…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer [Phase 2]
Phase 2 trial of NIS793 in combination with FOLFIRINOX for pancreatic cancer was terminated, with results posted on 2024-07-16.
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating neoadjuvant CAN-2409 with chemoradiation or SBRT for borderline resectable pancreatic adenocarcinoma; status ACTIVE…